On the biosynthetic origin of methoxymalonyl-acyl carrier protein, the substrate for incorporation of "glycolate" units into ansamitocin and soraphen A.

Silke C. Wenzel,Rachel M. Williamson,Christian Grünanger,Jun Xu,Klaus Gerth,Rodolfo A. Martinez,Steven J. Moss,Brian J. Carroll,Stephanie Grond,Clifford J. Unkefer,Rolf Müller,Heinz G. Floss
DOI: https://doi.org/10.1021/ja064408t
IF: 15
2006-01-01
Journal of the American Chemical Society
Abstract:Feeding experiments with isotope-labeled precursors rule out hydroxypyruvate and TCA cycle intermediates as the metabolic source of methoxymalonyl-ACP, the substrate for incorporation of "glycolate" units into ansamitocin P-3, soraphen A, and other antibiotics. They point to 1,3-bisphosphoglycerate as the source of the methoxymalonyl moiety and show that its C-1 gives rise to the thioester carbonyl group (and hence C-1 of the "glycolate" unit), and its C-3 becomes the free carboxyl group of methoxymalonyl-ACP, which is lost in the subsequent Claisen condensation on the type I modular polyketide synthases (PKS). D-[1,2-C-13(2)] Glycerate is also incorporated specifically into the "glycolate" units of soraphen A, but not of ansamitocin P-3, suggesting differences in the ability of the producing organisms to activate glycerate. A biosynthetic pathway from 1,3-bisphosphoglycerate to methoxymalonyl-ACP is proposed. Two new syntheses of R-and S-[1,2-C-13(2)] glycerol were developed as part of this work.
What problem does this paper attempt to address?